Original title: Tracing high-profile attention to questionable research as a case for funder due diligence
Federica Silvi, Leslie D. McIntosh · August 2026
Some researchers cheat by buying their names onto scientific papers they did not write. Once these untrustworthy papers get published, other experts might trust them. To see the real-world impact, researchers tracked a fake authorship network that was exposed in August 2022. They looked up where these papers were cited and checked if the cheating authors kept working. The results show real risks. These questionable papers shaped patents, policy papers, and medical treatment guidelines. Furthermore, having fake papers on their records did not stop the authors from advancing their careers. Almost all of the tracked authors kept publishing new studies, and nearly a quarter won research grants after the network was exposed. Because this bought research still misleads doctors and lawmakers, science funders must actively check author networks before giving out money.
Imagine choosing a restaurant by its online reviews. The reviews are glowing, so you book a table, but the food is terrible. Later you find out the owner paid for those reviews. Yet the restaurant still gets listed in a trusted travel guide, and the owner is already opening a second location. Here, the bought reviews are the fake papers, the travel guide is policy and clinical guidelines, and the second location is the grant money that keeps flowing.
Funders and policymakers assume peer review filters out bad science. This study shows questionable papers still end up in clinical guidelines and patents, and their authors keep getting grants. That means public money and medical advice can rest on fraudulent work unless funders check authorship networks, not just citations.
The abstract doesn't say. It traces a single known network, so the numbers may not generalize. It counts citations in policy documents and patents, not whether the research actually changed decisions. Grant links show association, not that the questionable paper was the reason for funding.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Tracing high-profile attention to questionable research as a case for funder due diligence — Federica Silvi, Leslie D. McIntosh
Abstract licence: CC0
Explanation generated by Synthesis from the abstract — it is not the original paper. This is a preprint, so it hasn't necessarily been peer reviewed.